Gregg Russo - 20 Nov 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief HR Officer
Signature
/s/ Gregg Russo
Issuer symbol
CPRX
Transactions as of
20 Nov 2025
Net transactions value
$0
Form type
4
Filing time
24 Nov 2025, 20:08:35 UTC
Previous filing
28 Feb 2025
Next filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Russo Gregg Chief HR Officer 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ Gregg Russo 24 Nov 2025 0002058326

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +20,531 +45% $0.000000 66,276 20 Nov 2025 Common Stock 20,531 $22.77 Direct F1
transaction CPRX Restricted Stock Units Award $0 +6,197 +9.4% $0.000000 72,473 20 Nov 2025 Common Stock 6,197 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027, and 1/3rd on November 20, 2028.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.